The GCC healthcare industry is poised for strong growth driven by macro-economic factors, a growing and ageing population, and the expansion of mandatory health insurance. Government-led diversification strategies and national development plans of the GCC will continue to enhance the healthcare infrastructure and facilities, bringing them at par with international standards. Key trends shaping the industry include the rapid adoption of artificial intelligence and digitalization, which are enhancing diagnostics, patient care, and operational efficiency. Looking ahead, we foresee a dynamic M&A landscape, as operators seek to scale, innovate, and align with the region’s evolving healthcare demands.
Alpen Capital’s comprehensive industry research reports on the healthcare sector provides in-depth analysis and forecasts for the sector, examines recent trends, growth drivers and challenges facing this dynamic segment. Additionally, the report profiles select healthcare operators in the region.
Featured Report
GCC Healthcare Industry Report
According to Alpen Capital, CHE in the GCC is expected to grow from an estimated US$ 109.1 billion in 2024 to US$ 159 billion in 2029, at a CAGR of 7.8%. The region’s expanding population base, high incidence of NCDs, rising cost of treatment and medical inflation, coupled with increasing penetration of health insurance are expected to drive growth.
CHE as a proportion of GDP in the GCC is anticipated to grow from 5.0% in 2024 to 5.7% in 2029.
The growth varies widely among the GCC nations largely owing to country-specific population projections, economic conditions and cost of healthcare among other factors. Saudi Arabia is likely to witness the highest growth rate at 8.8%, whereas the UAE’s healthcare industry is expected to grow at a CAGR of 6.7% during the forecast period. . The market rankings are expected to remain unchanged, with Saudi Arabia and the UAE dominating the region’s CHE with a combined share of 82.6% by 2029. CHE of Qatar, Kuwait, Bahrain and Oman is expected to grow at CAGRs of 8.3%, 6.3%, 6.0% and 4.0%, respectively between 2024-2029.
Select Transactions
Let's Connect
Alpen Capital is actively advising players within the healthcare industry to capitalize on the array of opportunities that the region presents owing to the privatization initiatives and increasing adoption of technology to create alternative healthcare models.
